A. Ruth

发表

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

S. Durgam, I. Laszlovszky, Dayong Li, 2014, Schizophrenia Research.

Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.

H. Meltzer, S. Durgam, I. Laszlovszky, 2015, The Journal of clinical psychiatry.

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial

J. Kane, S. Zukin, S. Durgam, 2015, Journal of clinical psychopharmacology.

Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.

G. Sachs, S. Durgam, I. Laszlovszky, 2015, Journal of affective disorders.

Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.

J. Calabrese, P. Keck, S. Durgam, 2015, The Journal of clinical psychiatry.

The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial

S. Durgam, I. Laszlovszky, Dayong Li, 2011, Bipolar disorders.

Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies

S. Durgam, C. Gommoll, Xiongwen Tang, 2016, Neuropsychiatric disease and treatment.

Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.

S. Durgam, L. Yatham, I. Laszlovszky, 2018, Journal of affective disorders.

Evaluation of functional health and well-being in patients receiving levomilnacipran ER for the treatment of major depressive disorder.

S. Blum, S. Tourkodimitris, A. Ruth, 2015, Journal of affective disorders.

P.2.e.016 Cariprazine in the treatment of acute mania in bipolar disorder: a double-blind, placebo-controlled, phase III trial

I. Laszlovszky, G. Németh, J. Goodman, 2012, European Neuropsychopharmacology.

Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials

E. Vieta, S. Zukin, S. Durgam, 2015, European Neuropsychopharmacology.

P.2.d.026 Efficacy and safety of low- and high-dose cariprazine in patients with acute mania associated with bipolar I disorder

J. Calabrese, S. Durgam, I. Laszlovszky, 2013, European Neuropsychopharmacology.

P.2.d.022 Cariprazine effects on YMRS items: results of a pooled analysis of 3 randomized, double-blind, placebo-controlled trials in bipolar mania

S. Zukin, I. Laszlovszky, G. Németh, 2013, European Neuropsychopharmacology.

P.3.d.033 Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, randomised, double-blind, placebo- and active-controlled trial

J. Lieberman, S. Durgam, I. Laszlovszky, 2013, European Neuropsychopharmacology.

Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study.

S. Montgomery, L. Mansuy, Dayong Li, 2013, The Journal of clinical psychiatry.

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study

S. Montgomery, C. Gommoll, L. Mansuy, 2013, International clinical psychopharmacology.

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder

M. Thase, J. Edwards, Dalei Chen, 2014, International clinical psychopharmacology.

Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder

M. Fava, C. Gommoll, M. Freeman, 2016, International clinical psychopharmacology.